The Drug Shortage App from LogicStream Health Wins 2019 MedTech “Clinical Efficiency Innovation Award”

June 10, 2019

LogicStream Health announced that The Drug Shortage App from LogicStream Health won the “Clinical Efficiency Innovation Award” by MedTech Breakthrough, an independent organization that recognizes technological innovation in the health and medical industries. This award comes from MedTech Breakthrough’s annual awards program, which garnered more than 3,500 nominations from across the globe. In a news release, LogicStream says the Drug Shortage App addresses the growing concern of the drug shortage crisis in the U.S. healthcare system, and its many negative repercussions.

“The annual awards program celebrates the world’s most outstanding Digital Health and Medical Technology products, services and companies, and LogicStream Health’s Drug Shortage App is certainly one to celebrate,” said James Johnson, managing director, MedTech Breakthrough. “This organization and product is actively working to address a real concern within the healthcare industry, and they continue to use innovation and creativity to do so.”

According to the Food and Drug Administration, the number and duration of prescription drug shortages is growing and has led to:

·   rising drug costs

·   a negative impact on pharmacist productivity levels

·   compromised or delayed medical procedures and drug therapy efforts

·   healthcare professionals forced to turn to other medications, which can lead to increased risks to patient safety

The Drug Shortage Appworks to provide healthcare professionals and hospital pharmacists necessary early-warning information to manage both supply and demand for specific medications during a shortage. The app allows professionals to see which clinicians frequently prescribe and dispense certain medications, to manage inventory levels, and evaluate when the shortage is over.

Patrick Yoder, PharmD, Co-Founder and CEO, LogicStream Health, said, “Our groundbreaking drug shortage app has tremendous momentum this year with several new major U.S. health systems signing up and a healthy ongoing demand and pipeline.”